Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005
- PMID:21217399
- DOI: 10.1097/COC.0b013e3181fe41ed
Trends in colorectal cancer incidence by anatomic site and disease stage in the United States from 1976 to 2005
Abstract
Objective: The objectives of the current study were to examine the trends in incidence rates of subsite-specific colorectal cancer at all stages in a large US population and to explore the impact of age and sex on colorectal cancer incidence.
Methods: Data were obtained from the Surveillance, Epidemiology, and End Results (SEER) 9 registries. Colorectal cancer incidence was divided into 3 anatomic subsite groupings: proximal colon, distal colon, and rectum. Incidence rates and relative risk were calculated using the SEER*Stat software provided by the National Cancer Institute.
Results: From 1976 to 2005, age-adjusted incidence of proximal colon, distal colon, and rectal cancers per 100,000 population have steadily decreased from 22.5, 18.8, and 19.2 to 21.1, 11.7, and 13.6, respectively, contributing to the overall decline in the incidence of colorectal cancer from 60.5 to 46.4. Distal colon cancer had the greatest incidence decline (-37.79%), whereas the most minimal change in the incidence rates occurred for proximal colon cancer (-6.37%) because of increased incidence rates of ascending colon (24.8%) and hepatic flexure (21.3%) over 30 years. The steadily increased proportion of proximal colorectal cancer subsites was observed in both men and women starting at age 50 although women experienced a greater increase than did men.
Conclusions: Overall incidence rate of colorectal cancer decreased over the past 3 decades. The percent of ascending colon and hepatic flexure cancers diagnosed at early stages (localized and regional) increased. The finding on sex difference over years suggests that great attention should be paid in the future studies to male and female disparities.
Similar articles
- Colorectal cancer incidence trends by subsite in urban Shanghai, 1972-1994.Ji BT, Devesa SS, Chow WH, Jin F, Gao YT.Ji BT, et al.Cancer Epidemiol Biomarkers Prev. 1998 Aug;7(8):661-6.Cancer Epidemiol Biomarkers Prev. 1998.PMID:9718217
- Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS.Rim SH, et al.Cancer. 2009 May 1;115(9):1967-76. doi: 10.1002/cncr.24216.Cancer. 2009.PMID:19235249
- Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992-2001.Cress RD, Morris C, Ellison GL, Goodman MT.Cress RD, et al.Cancer. 2006 Sep 1;107(5 Suppl):1142-52. doi: 10.1002/cncr.22011.Cancer. 2006.PMID:16835912
- Cancer treatment and survivorship statistics, 2014.DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, Alteri R, Robbins AS, Jemal A.DeSantis CE, et al.CA Cancer J Clin. 2014 Jul-Aug;64(4):252-71. doi: 10.3322/caac.21235. Epub 2014 Jun 1.CA Cancer J Clin. 2014.PMID:24890451Review.
- Why have ovarian cancer mortality rates declined? Part I. Incidence.Sopik V, Iqbal J, Rosen B, Narod SA.Sopik V, et al.Gynecol Oncol. 2015 Sep;138(3):741-9. doi: 10.1016/j.ygyno.2015.06.017. Epub 2015 Jun 14.Gynecol Oncol. 2015.PMID:26080287Review.
Cited by
- Single-centre evaluation and staging of rectal carcinoma on a 3-Tesla magnetic resonance imaging and correlation with histological profile.Amankulov J, Akhmetova G, Toleshbaev D, Zholdybay Z, Mangitova L, Kaidarova D.Amankulov J, et al.Pol J Radiol. 2021 Apr 20;86:e217-e224. doi: 10.5114/pjr.2021.105607. eCollection 2021.Pol J Radiol. 2021.PMID:34093918Free PMC article.
- AVL9 is Upregulated in and Could Be a Predictive Biomarker for Colorectal Cancer.Li D, Zeng Y, Shen P, Lin X, Yang T, Chen B, Ma Z, Wang H.Li D, et al.Cancer Manag Res. 2021 Apr 9;13:3123-3132. doi: 10.2147/CMAR.S301844. eCollection 2021.Cancer Manag Res. 2021.PMID:33859498Free PMC article.
- Trends and variations in breast and colorectal cancer incidence from 1995 to 2011: a comparative study between Texas Cancer Registry and National Cancer Institute's Surveillance, Epidemiology and End Results data.Liu Z, Zhang Y, Franzin L, Cormier JN, Chan W, Xu H, Du XL.Liu Z, et al.Int J Oncol. 2015 Apr;46(4):1819-26. doi: 10.3892/ijo.2015.2881. Epub 2015 Feb 6.Int J Oncol. 2015.PMID:25672365Free PMC article.
- Role of targeted therapy in metastatic colorectal cancer.Ohhara Y, Fukuda N, Takeuchi S, Honma R, Shimizu Y, Kinoshita I, Dosaka-Akita H.Ohhara Y, et al.World J Gastrointest Oncol. 2016 Sep 15;8(9):642-55. doi: 10.4251/wjgo.v8.i9.642.World J Gastrointest Oncol. 2016.PMID:27672422Free PMC article.Review.
- Construction of prognostic predictor by comprehensive analyzing alternative splicing events for colon adenocarcinoma.Qu Y, Chen Y, Zhang L, Tian L.Qu Y, et al.World J Surg Oncol. 2020 Sep 3;18(1):236. doi: 10.1186/s12957-020-02010-7.World J Surg Oncol. 2020.PMID:32883335Free PMC article.
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous